Intuitive Surgical/$ISRG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Intuitive Surgical
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
Ticker
$ISRG
Sector
Primary listing
Employees
15,638
Headquarters
Website
ISRG Metrics
BasicAdvanced
$193B
72.16
$7.56
1.61
-
Price and volume
Market cap
$193B
Beta
1.61
52-week high
$616.00
52-week low
$425.00
Average daily volume
2.6M
Financial strength
Current ratio
6.597
Quick ratio
3.49
Profitability
EBITDA (TTM)
3,411.9
Gross margin (TTM)
66.38%
Net profit margin (TTM)
28.58%
Operating margin (TTM)
29.52%
Effective tax rate (TTM)
12.65%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
9.56%
Return on equity (TTM)
16.90%
Valuation
Price to earnings (TTM)
72.159
Price to revenue (TTM)
20.269
Price to book
11.43
Price to tangible book (TTM)
11.68
Price to free cash flow (TTM)
85.778
Free cash flow yield (TTM)
1.17%
Free cash flow per share (TTM)
6.358
Growth
Revenue change (TTM)
22.18%
Earnings per share change (TTM)
21.56%
3-year revenue growth (CAGR)
16.25%
10-year revenue growth (CAGR)
15.45%
3-year earnings per share growth (CAGR)
26.07%
10-year earnings per share growth (CAGR)
16.72%
What the Analysts think about ISRG
Analyst ratings (Buy, Hold, Sell) for Intuitive Surgical stock.
Bulls say / Bears say
Intuitive’s second-quarter 2025 revenue rose 21% year-over-year to $2.44 billion, fueled by growth in da Vinci procedure volume and increased system placements, showing clear acceleration from previous quarters.
The company’s installed base rose 14% year-over-year to 10,488 da Vinci systems as of June 30, 2025—a sign of strong customer adoption—driven by 395 system placements in Q2 2025 with 180 being da Vinci 5.
Intuitive hit major regulatory milestones in mid-2025, earning EU MDR certification for da Vinci 5 in July and Japanese clearance in June for expanded procedure indications, expanding its potential market in both regions.
Intuitive expects its non-GAAP gross profit margin to drop to 66–67% of revenue in 2025 from 69.1% in 2024, highlighting about a 1% tariff impact, which could put pressure on margins.
The company forecasts non-GAAP operating expense growth of 10–14% for 2025, up from 10% in 2024, indicating that higher spending may limit operating leverage and affect profitability.
Competition is growing; CMR Surgical’s Versius system, which has raised nearly $1 billion and installed over 200 units globally, is starting to challenge Intuitive’s established leadership in robotic surgery.
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2025.
ISRG Financial Performance
Revenues and expenses
ISRG Earnings Performance
Company profitability
ISRG News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Intuitive Surgical stock?
Intuitive Surgical (ISRG) has a market cap of $193B as of October 29, 2025.
What is the P/E ratio for Intuitive Surgical stock?
The price to earnings (P/E) ratio for Intuitive Surgical (ISRG) stock is 72.16 as of October 29, 2025.
Does Intuitive Surgical stock pay dividends?
No, Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders as of October 29, 2025.
When is the next Intuitive Surgical dividend payment date?
Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders.
What is the beta indicator for Intuitive Surgical?
Intuitive Surgical (ISRG) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.